Table 3 Association of Vitamin D and Parathormone values with socio-demographic and clinical characteristics of the patients

Diagnosis

Hodgkin lymphoma

1 (25.0)

2 (75.0)

0.46

0 (0.0)

3 (100.0)

0.56

Non-Hodgkin lymphoma

4 (16.0)

21 (84.0)

6 (23.1)

20 (76.9)

Age

63.0 (21.0)

66.0 (26.5)

0.49

62.0 (23.5)

77.0 (4.5)

0.02

Gender

Male

5 (26.3)

14 (73.7)

0.14

5 (26.3)

14 (73.7)

0.63

Female

0 (0.0)

9 (100.0)

1 (10.)

9 (90.0)

Chemo and steroid therapy

Yes

2 (12.5)

14 (87.5)

0.63

6 (37.5)

10 (62.5)

0.02

No

3 (23.1)

10 (76.9)

0 (0)

13 (100)

Comorbidities

Yes

4 (18.2)

18 (81.8)

0.99

6 (27.3)

16 (72.7)

0.15

No

1 (14.3)

6 (85.7)

0 (0)

7 (100)

Vertebral fractures

Yes

2 (10.5)

17 (89.5)

0.29

6 (31.6)

13 (68.4)

0.05

No

3 (33.3)

6 (66.7)

0 (0.0)

10 (100)

Femoral DEXA

Normal

3 (20.0)

12 (80.0)

0.83

3 (20.0)

12 (80.0)

0.99

Osteopenia / Osteoporosis

1 (9.1)

10 (90.9)

3 (25.0)

9 (75.0)

Vertebral DEXA

Normal

2 (14.3)

12 (85.7)

0.57

3 (21.4)

11 (78.6)

0.93

Osteopenia / Osteoporosis

3 (23.1)

10 (76.9)

3 (21.4)

11 (78.6)

Vitamin D (ng/ml)

Normal

/

/

/

0 (0.0)

5 (100.0)

0.30

Insuffiency / Deficiency

6 (26.1)

17 (73.9)

SARC-F (patients with 1 or 2 points)

≥4 (sarcopenic)

1 (5.9)

16 (94.1)

0.06

3 (16.7)

15 (83.3)

0.65

< 4 (non sarcopenic)

4 (36.4)

7 (63.6)

3 (27.3)

8 (72.7)

Mini-OQoL total score

10–35

1 (50,0)

1 (50,0)

2 (100,0)

0 (0,0)

0.14

36–60

2 (12,5)

14 (87,5)

0.63

11 (68,7)

5 (31,3)

61–70

2 (20,0)

8 (80,0)

10 (90,9)

1 (9,1)